Biomedicine and Chemical Sciences
2023, Volume 2, Issue 2 : 125-130 doi: https://doi.org/10.48112/bcs.v2i2.444
Research Article
Remdesivir: Identification, Determination and Spectral Study
 ,
Received
Jan. 18, 2023
Revised
March 1, 2023
Accepted
March 12, 2023
Published
April 1, 2023
Abstract

Corona viruses resist many antiviral agents which reduces the antiviral therapies. Remdesivir is an antiviral drug efficient against single-stranded RNA viruses. Analytical determinations of this drug are very benefit in selecting the correct dose and getting real information and formulas of this compound. In this work, remdesivir has been identified at 239 nm in aqueous alkaline (1M NaOH), at 245 nm in ethanol, and at 246 nm. in methanol, it has also been followed at 239 nm using the alkaline medium and determined in injection, the linearity range was from 1to 60 µg/ml with molar absorptivity 2.036×10l.mol-1.cm-1, and Sandell’s sensitivity index is 0.0295 µg.cm-2, LOD is 0.2613 and LOQ is 0.871 µg/mL. I. R spectrum of solid remdesivir shows band at 1639.96 cm -1 due to the carbonyl group and at 3350.79 cm-1refer to the hydroxy group adjacent to NH2 group which appears at about 3300 cm-1, the aromatic was identified at 1660-2000 cm-1 and C-O of ester at 1153cm-1. These bands in the alkaline medium were slightly shifted to be 1637 cm -1 due to carbonyl group and at 3318 cm-1refer to hydroxy group adjacent to NH2 group which appeared at about 3264 cm-1, the aromatic was identified at 2131 cm-1, and C-O of ester at 1379cm-1.

Keywords
REFERENCES
  1. Abdel Moneim, M. M., Kamal, M. F., & Hamdy, M. M. (2021). Rapid sensitive bioscreening of remdesivir in COVID-19 medication: Selective drug determination in the presence of six co-administered therapeutics. Reviews in Analytical Chemistry, 40(1), 323-333. https://doi.org/10.1515/revac-2021-0141
  2. Al-Tannak, N. F., Novotny, L., & Alhunayan, A. (2020). Remdesivir—bringing hope for COVID-19 treatment. Scientia Pharmaceutica, 88(2), 29. https://doi.org/10.3390/scipharm88020029
  3. Alvarez, J. C., Moine, P., Etting, I., Annane, D., & Larabi, I. A. (2020). Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient. Clinical Chemistry and Laboratory Medicine (CCLM), 58(9), 1461-1468. https://doi.org/10.1515/cclm-2020-0612
  4. Attia, T. Z., Boushra, J. M., Abdel Hakiem, A. F., Lashien, A. S., & Noureldeen, D. A. (2022). Spectrofluorimetric determination of the anti‐Covid 19 agent, remdesivir, in vials and spiked human plasma. Luminescence, 37(7), 1192-1199. https://doi.org/10.1002/bio.4274
  5. Avataneo, V., De Nicolò, A., Cusato, J., Antonucci, M., Manca, A., Palermiti, A., ... & D’Avolio, A. (2020). Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. Journal of Antimicrobial Chemotherapy, 75(7), 1772-1777. https://doi.org/10.1093/jac/dkaa152
  6. Camões, M. F., & Anes, B. (2019). Hydrated Protons. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. https://doi.org/10.1016/B978-0-12-409547-2.14298-2
  7. Christian, G. D., Dasgupta, P. K., & Schug, K. A. (2013). Analytical chemistry. John Wiley & Sons.
  8. Darwish, I. A., Khalil, N. Y., Darwish, H. W., Alzoman, N. Z., & Al-Hossaini, A. M. (2022). Synthesis, spectroscopic and computational characterization of charge transfer complex of remdesivir with chloranilic acid: Application to development of novel 96-microwell spectrophotometric assay. Journal of Molecular Structure, 1263, 133104. https://doi.org/10.1016/j.molstruc.2022.133104
  9. Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020). Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS central science, 6(5), 672-683. https://doi.org/10.1021/acscentsci.0c00489
  10. Elmansi, H., Ibrahim, A. E., Mikhail, I. E., & Belal, F. (2021). Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma. Analytical Methods, 13(23), 2596-2602. https://doi.org/10.1039/D1AY00469G
  11. Emam, A. A., Abdelaleem, E. A., Abdelmomen, E. H., Abdelmoety, R. H., & Abdelfatah, R. M. (2022). Rapid and ecofriendly UPLC quantification of Remdesivir, Favipiravir and Dexamethasone for accurate therapeutic drug monitoring in Covid-19 Patient’s plasma. Microchemical Journal, 179, 107580. https://doi.org/10.1016/j.microc.2022.107580
  12. Lamb, Y. N. (2020). Remdesivir: first approval. Drugs, 80, 1355-1363. https://doi.org/10.1007/s40265-020-01378-w
  13. Murphy, B. G., Perron, M., Murakami, E., Bauer, K., Park, Y., Eckstrand, C., ... & Pedersen, N. C. (2018). The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Veterinary microbiology, 219, 226-233. https://doi.org/10.1016/j.vetmic.2018.04.026
  14. Noureldeen, D. A., Boushra, J. M., Lashien, A. S., Hakiem, A. F. A., & Attia, T. Z. (2022). Novel environment friendly TLC-densitometric method for the determination of anti-coronavirus drugs “Remdesivir and Favipiravir”: Green assessment with application to pharmaceutical formulations and human plasma. Microchemical Journal, 174, 107101. https://doi.org/10.1016/j.microc.2021.107101
  15. Pashaei, Y. (2020). Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic. Drug Discoveries & Therapeutics, 14(6), 273-281. https://doi.org/10.5582/ddt.2020.03097
  16. Rizk, M., Sultan, M. A., Tawfik, B. M., & El-Eryan, R. T. (2022). Highly Sensitive and Selective Sensing Probe for Determination of Anti-Covid-19 Remdesvir: Application to Pharmaceutical Dosage Form and Biological Fluids. Journal of The Electrochemical Society, 169(2), 026522. https://doi.org/10.1149/1945-7111/ac53ca
  17. Sahakijpijarn, S., Moon, C., Koleng, J. J., Christensen, D. J., & Williams Iii, R. O. (2020). Development of remdesivir as a dry powder for inhalation by thin film freezing. Pharmaceutics, 12(11), 1002. https://doi.org/10.3390/pharmaceutics12111002
  18. Sahakijpijarn, S., Moon, C., Warnken, Z. N., Maier, E. Y., DeVore, J. E., Christensen, D. J., ... & Williams III, R. O. (2021). In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters. International Journal of Pharmaceutics: X, 3, 100073. https://doi.org/10.1016/j.ijpx.2021.100073
  19. Skaggs, C., Zimmerman, H., Manicke, N., & Kirkpatrick, L. (2022). Development and validation of a paper spray mass spectrometry method for the rapid quantitation of remdesivir and its active metabolite, GS-441524, in human plasma. Journal of Mass Spectrometry and Advances in the Clinical lab, 25, 27-35. https://doi.org/10.1016/j.jmsacl.2022.06.001
  20. Yan, V. C., & Muller, F. L. (2020). Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment. ACS medicinal chemistry letters, 11(7), 1361-1366. https://doi.org/10.1021/acsmedchemlett.0c00316
Recommended Articles
Research Article Open Access
Investigation of Tritrichomonas Foetus in Cattle Using Different Methods in Basrah City – Iraq
2023, Volume 2, Issue 1 : 39-43
DOI: https://doi.org/10.48112/bcs.v2i1.334
Original Article Open Access
A FRAMEWORK OF MONOCLONAL ANTIBODIES AND RELATED PRODUCTION ENGINEERING
2025, Volume 4, Issue 4 : 26-34
Research Article Open Access
The Role of Vitamin D and Zinc In Facing COVID-19 Injury
2022, Volume 1, Issue 1 : 6-10
DOI: https://doi.org/10.48112/bcs.v1i1.76
Research Article Open Access
Prevalence and Risk Factors of Obesity in Children
2022, Volume 1, Issue 1 : 20-23
DOI: https://doi.org/10.48112/bcs.v1i1.81
Biomedicine and Chemical Sciences journal thumbnail
Volume 2, Issue 2
Citations
3 Views
0 Downloads
Share this article
License
Copyright (c) Biomedicine and Chemical Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Biomed. Chem. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Biomedicine and Chemical Sciences Logo
Biomedicine and Chemical Sciences
About Us
Biomedicine and Chemical Sciences (BCS), an international journal, publishes double blind peer-reviewed full-length, original papers, reviews or letters. BCS covers the latest developments in various fields of biomedicine such as cardiology, immunology, genetics, environmental health, neurology, oncology and toxicology
Support
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright Biomedicine and Chemical Sciences (BCS). All Rights Reserved.